Cas:959979-30-7 (S)-2-[[3,5-Bis(trifluoromethyl)phenyl]thioureido]-N-benzyl-N,3,3-trimethylbutanamide manufacturer & supplier

Chemical Name:(S)-2-[[3,5-Bis(trifluoromethyl)phenyl]thioureido]-N-benzyl-N,3,3-trimethylbutanamide

CAS.NO:959979-30-7

Synonyms:N-Benzyl-N-{[3,5-bis(trifluoromethyl)phenyl]carbamothioyl}-N,3-dimethyl-L-valinamide;(S)-2-[[3,5-Bis(trifluoromethyl)phenyl]thioureido]-N-benzyl-N,3,3-trimethylbutanamide;(2S)-2-[[[[3,5-Bis(trifluoromethyl)phenyl]amino]thioxomethyl]amino]-N-3,3-trimethyl-N-(phenylmethyl)butanamide;Butanamide, 2-[[[[3,5-bis(trifluoromethyl)phenyl]amino]thioxomethyl]amino]-N,3,3-trimethyl-N-(phenylmethyl)-, (2S)-;2-[3-[3,5-bis(trifluoromethyl)phenyl]thioureido]-N-benzyl-N,3,3-trimethylbutanamide;1-((S)-1-(N-benzyl-N-methylcarbamoyl)-2,2-dimethylpropyl)-3-(3,5-bis(trifluoromethyl)phenyl)thiourea

Molecular Formula:C₂₃H₂₅F₆N₃OS

Molecular Weight:505.520

HS Code:

Physical and Chemical Properties:

Melting point:147-152 °C

Boiling point:497.5±55.0 °C at 760 mmHg

Density:1.3±0.1 g/cm3

Index of Refraction:1.542

PSA:83.50000

Exact Mass:505.162262

LogP:6.50

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like N-Benzyl-N-{[3,5-bis(trifluoromethyl)phenyl]carbamothioyl}-N,3-dimethyl-L-valinamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-((S)-1-(N-benzyl-N-methylcarbamoyl)-2,2-dimethylpropyl)-3-(3,5-bis(trifluoromethyl)phenyl)thiourea physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-Benzyl-N-{[3,5-bis(trifluoromethyl)phenyl]carbamothioyl}-N,3-dimethyl-L-valinamide Use and application,(2S)-2-[[[[3,5-Bis(trifluoromethyl)phenyl]amino]thioxomethyl]amino]-N-3,3-trimethyl-N-(phenylmethyl)butanamide technical grade,usp/ep/jp grade.

Related News: The collaborative research and exclusive license agreement inked in December didn’t have a price tag, but the two companies revealed the eye-popping figure Tuesday that includes an undisclosed upfront payment to PeptiDream and other cash drops subject to certain clinical milestones. HEPARIN manufacturers MG is a “serious, lifelong disease with life-threatening manifestations, and most patients do not achieve treatment goals with conventional therapy,” the report said. Hydroxytriclabendazole suppliers The CDC’s Advisory Committee on Immunization Practices (ACIP) decision on Thursday came after an hours-long discussion over a handful of Guillain-Barré syndrome (GBS) cases reported after J&J’s jab. The independent group of experts were also tasked with reviewing the need for booster shots, specifically for people with compromised immune systems. Barium naphthenate vendor & factory.